Centessa Pharmaceuticals PLC (CNTA)
15.98
+0.08
(+0.53%)
USD |
NASDAQ |
Nov 05, 16:00
15.98
0.00 (0.00%)
After-Hours: 20:00
Centessa Pharmaceuticals Enterprise Value: 1.826B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.826B |
| November 01, 2024 | 1.796B |
| October 31, 2024 | 1.715B |
| October 30, 2024 | 1.722B |
| October 29, 2024 | 1.767B |
| October 28, 2024 | 1.776B |
| October 25, 2024 | 1.774B |
| October 24, 2024 | 1.774B |
| October 23, 2024 | 1.729B |
| October 22, 2024 | 1.769B |
| October 21, 2024 | 1.812B |
| October 18, 2024 | 1.845B |
| October 17, 2024 | 1.814B |
| October 16, 2024 | 1.876B |
| October 15, 2024 | 1.850B |
| October 14, 2024 | 1.924B |
| October 11, 2024 | 1.837B |
| October 10, 2024 | 1.795B |
| October 09, 2024 | 1.780B |
| October 08, 2024 | 1.849B |
| October 07, 2024 | 1.776B |
| October 04, 2024 | 1.831B |
| October 03, 2024 | 1.823B |
| October 02, 2024 | 1.872B |
| October 01, 2024 | 1.993B |
| Date | Value |
|---|---|
| September 30, 2024 | 1.837B |
| September 27, 2024 | 1.812B |
| September 26, 2024 | 1.796B |
| September 25, 2024 | 1.754B |
| September 24, 2024 | 1.777B |
| September 23, 2024 | 1.783B |
| September 20, 2024 | 1.913B |
| September 19, 2024 | 1.819B |
| September 18, 2024 | 1.801B |
| September 17, 2024 | 1.875B |
| September 16, 2024 | 1.898B |
| September 13, 2024 | 1.707B |
| September 12, 2024 | 1.493B |
| September 11, 2024 | 1.340B |
| September 10, 2024 | 1.434B |
| September 09, 2024 | 1.473B |
| September 06, 2024 | 1.402B |
| September 05, 2024 | 1.436B |
| September 04, 2024 | 1.439B |
| September 03, 2024 | 1.311B |
| August 30, 2024 | 1.311B |
| August 29, 2024 | 1.259B |
| August 28, 2024 | 1.309B |
| August 27, 2024 | 1.311B |
| August 26, 2024 | 1.359B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-170.61M
Minimum
Jun 06 2022
2.256B
Maximum
Jun 17 2021
561.48M
Average
433.35M
Median
Enterprise Value Benchmarks
| Biodexa Pharmaceuticals PLC | -2.612M |
| Verona Pharma PLC | 2.817B |
| Autolus Therapeutics PLC | 182.82M |
| Mereo BioPharma Group PLC | 534.45M |
| Achilles Therapeutics PLC | -53.00M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -43.82M |
| Total Expenses (Quarterly) | 43.98M |
| EPS Diluted (Quarterly) | -0.40 |
| Earnings Yield | -9.70% |